Nov. 6, 2018
Tyratech is a life sciences company focused on nature-derived insect and parasite control products. Prior to the transaction, American Vanguard held approximately 35% of the shares of Tyratech. The transaction, including de-listing of Tyratech shares from the AIM market, is expected to close on November 8, 2018.
Further details of the deal were not disclosed.
Eric Wintemute, Chairman and CEO of American Vanguard, stated, "We are excited to have acquired Tyratech, which has spent over a decade developing non-toxic insecticides and green solutions for pest control. Their patented technology platform leverages synergistic essential oil combination to target invertebrate pest receptors that are not active in humans and other mammals. Thus, they are highly effective and safe for use around people and pets.
"This acquisition complements our Envance portfolio, which uses the same technology platform in consumer, professional and agricultural applications, and will enable us to expand our market into mosquito repellent, animal health and other sectors."